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Conclusion: Surgical malpractice claims are demonstrating increasing
payment amounts, with patient outcomes the strongest predictor of payment
size.
Summary: The effect of medical liability on the health care system is
more than the sum of payments to plaintiffs. Other costs include practicing
defensive medicine, administrative expenses, and attorney fees, among
others. It has been estimated that all of these costs combined to account
for 2.4% of health care expenditures (w$55.6 billion dollars annually; Mello
MN et al, Health AFF (Millwood) 2010;29:1569-77). Congress passed the
Healthcare Quality Improvement Act in 1988 in an attempt to identify
those who provided incompetent care. The National Practitioner Data
Bank (NPDB) was created by the U.S. Department of Health and Human
Services and has a mandatory reporting system of medical malpractice
payments. The NPDB contains data reported by malpractice carriers, hospi-
tals, and professional societies as well as state licensing boards since 1990.
Since the creation of the NPDB, there has not been an analysis of surgical
malpractice claims using this database. The authors of this study sought
to discover patterns and predictors of surgical malpractice payments and,
speciﬁcally, to evaluate predictors of large payments. This was a retrospective
analysis of surgery-related malpractice payments using the NPBD from
1990 to 2006 with payments adjusted to 2006 dollars. Predictors of
payment size and payments considered large (>$1 million) were evaluated.
Statutory law in the states demonstrating signiﬁcant predictive value was
also analyzed. There were 58,518 surgical malpractice claims that met inclu-
sion criteria. Patients were mostly female (62%) and inpatients (63%). Mean
age was 42 years. During the study period, the number of payments
decreased but payment sums increased. Median payments were $132,915
(95th percentile, $983,263). The most frequently cited reason for the claim
was improper performance (42%). Payment size and likelihood of a large
payment were both primarily predicated by patient outcomes. In addition,
children aged <10 years were 70% more likely to receive a large payment
(P ¼ .005), and patients aged >70 years were 80% less likely to receive
a large payment (P < .005). There were large variations among states for
payment size and likelihood of a large payment.
Comment: Of the >750,000 entries in the NPDB, 1% are surgery-
related malpractice claims. Surgeons have the highest perceived threat of
malpractice suits, and 90% of surgeons aged $55 years have been reported
to have been sued for medical malpractice (Kane CK, American Medical
Association; 2010). Variation in payment size among the states suggests
that the local legal environment has a signiﬁcant impact on payment size.
The implication is that local efforts to improve the medical malpracticeenvironment remain the most important possibility of achieving meaningful
medical malpractice reform.Traditional Cardiovascular Risk Factors Explained the Minority of the
Variability in Carotid Plaque
Kuo F, Gardener H, Dong C, et al. Stroke 2012;43:1755-60.
Conclusion: Variations in preclinical carotid plaque burden are largely
unexplained by traditional and less traditional vascular risk factors.
Summary: Few data are available on the variability of vascular risk
factors in population-based cohorts. Traditional vascular risk factors associ-
ated with carotid plaque area include pack-years of smoking, sex, age,
systolic and diastolic blood pressure, diabetes, blood pressure, lipid-lowering
medications, and high-density lipoprotein (HDL) cholesterol. However,
these data explain no more than 50% of the variants in total plaque area
of prior studies. The authors sought to identify traditional and less tradi-
tional vascular risk factors associated with carotid plaque area with the aim
of estimating their contribution to variation in carotid plaque area.
This study was conducted as part of the carotid substudy of The
Northern Manhattan Study (NOMAS). The study assessed 1790 stroke-
free individuals (mean age, 69 6 9.60 years; 61% Hispanic, 19% black, 18%
white) for total plaque area using two-dimensional carotid ultrasound
imaging. Two multiple linear regression models were constructed. Model 1
used the prespeciﬁed traditional risk factors of age, sex, low-density lipopro-
tein cholesterol, diabetes, pack-years of smoking, blood pressure, and blood
pressure treatment; andmodel 2 investigated the addition of social, economic,
and less traditional risk factors, and contributions of the components of the
Framingham Heart Risk Score and the NOMAS Global Vascular Risk Score
to the total plaque area were also explored. Among these 1790 stroke-free
individuals, the prevalence of carotid plaque was 58%. Mean total plaque
area was 136 19 mm2. Model 1 explained only 19.5% of the variants in total
plaque area (R2 ¼ 0.195), and model 2 explained only 21.9% of the total
plaque area burden. The Framingham Heart Risk Score explained 18.8%,
and the NOMAS Global Vascular Risk Score explained 21.5% of total plaque
area variants.
Comment: There are, of course, limitations to this study. The study
population was primarily Hispanic, thus limiting generalizability of the
results. However, it is striking that only a small percentage of carotid plaque
burden can be explained by the contribution of traditional and less traditional
vascular risk factors. The authors appropriately postulate that unaccounted
for risk factors, such as infection or inﬂammation, innate immunity, or behav-
ioral psychosocial factors, as well as genetic factors, must also contribute to
plaque burden.
